vs
BlackSky Technology Inc.（BKSY）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
BlackSky Technology Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.8倍（$35.2M vs $19.6M），BlackSky Technology Inc.净利率更高（-2.5% vs -177.4%，领先174.9%），BlackSky Technology Inc.同比增速更快（15.9% vs -11.5%），过去两年BlackSky Technology Inc.的营收复合增速更高（20.5% vs -12.2%）
BlackSky Technology Inc.是一家领先的地理空间情报服务商，运营高重访率小型地球观测卫星星座，为全球政府、国防、关键基础设施及商业客户提供实时卫星影像、高级数据分析与动态监测解决方案，助力各类场景下的运营决策。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
BKSY vs LAB — 直观对比
营收规模更大
BKSY
是对方的1.8倍
$19.6M
营收增速更快
BKSY
高出27.4%
-11.5%
净利率更高
BKSY
高出174.9%
-177.4%
两年增速更快
BKSY
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $35.2M | $19.6M |
| 净利润 | $-868.0K | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | -11.8% | -168.5% |
| 净利率 | -2.5% | -177.4% |
| 营收同比 | 15.9% | -11.5% |
| 净利润同比 | 95.5% | -28.8% |
| 每股收益（稀释后） | $0.04 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BKSYLAB
| Q4 25 | $35.2M | — | ||
| Q3 25 | $19.6M | $19.6M | ||
| Q2 25 | $22.2M | $21.8M | ||
| Q1 25 | $29.5M | $40.8M | ||
| Q4 24 | $30.4M | — | ||
| Q3 24 | $22.5M | $22.1M | ||
| Q2 24 | $24.9M | $22.5M | ||
| Q1 24 | $24.2M | $45.5M |
净利润BKSYLAB
| Q4 25 | $-868.0K | — | ||
| Q3 25 | $-15.3M | $-34.7M | ||
| Q2 25 | $-41.2M | $-33.5M | ||
| Q1 25 | $-12.8M | $-26.0M | ||
| Q4 24 | $-19.4M | — | ||
| Q3 24 | $-12.6M | $-26.9M | ||
| Q2 24 | $-9.4M | $-45.7M | ||
| Q1 24 | $-15.8M | $-32.2M |
毛利率BKSYLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率BKSYLAB
| Q4 25 | -11.8% | — | ||
| Q3 25 | -85.8% | -168.5% | ||
| Q2 25 | -62.8% | -118.1% | ||
| Q1 25 | -40.5% | -80.8% | ||
| Q4 24 | -20.0% | — | ||
| Q3 24 | -58.7% | -120.9% | ||
| Q2 24 | -47.0% | -134.5% | ||
| Q1 24 | -54.7% | -132.2% |
净利率BKSYLAB
| Q4 25 | -2.5% | — | ||
| Q3 25 | -78.2% | -177.4% | ||
| Q2 25 | -185.8% | -153.7% | ||
| Q1 25 | -43.4% | -63.8% | ||
| Q4 24 | -63.9% | — | ||
| Q3 24 | -55.8% | -122.0% | ||
| Q2 24 | -37.7% | -203.3% | ||
| Q1 24 | -65.2% | -70.6% |
每股收益（稀释后）BKSYLAB
| Q4 25 | $0.04 | — | ||
| Q3 25 | $-0.44 | $-0.09 | ||
| Q2 25 | $-1.27 | $-0.09 | ||
| Q1 25 | $-0.42 | $-0.07 | ||
| Q4 24 | $-0.61 | — | ||
| Q3 24 | $-0.66 | $-0.07 | ||
| Q2 24 | $-0.52 | $-0.12 | ||
| Q1 24 | $-0.88 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.5M | $129.4M |
| 总债务越低越好 | $201.1M | — |
| 股东权益账面价值 | $94.9M | $399.7M |
| 总资产 | $386.2M | $539.6M |
| 负债/权益比越低杠杆越低 | 2.12× | — |
8季度趋势，按日历期对齐
现金及短期投资BKSYLAB
| Q4 25 | $124.5M | — | ||
| Q3 25 | $146.5M | $129.4M | ||
| Q2 25 | $93.8M | $158.6M | ||
| Q1 25 | $75.8M | $150.9M | ||
| Q4 24 | $52.5M | — | ||
| Q3 24 | $63.2M | $210.6M | ||
| Q2 24 | $41.2M | $269.8M | ||
| Q1 24 | $35.4M | $287.1M |
总债务BKSYLAB
| Q4 25 | $201.1M | — | ||
| Q3 25 | $195.1M | — | ||
| Q2 25 | $122.5M | — | ||
| Q1 25 | $115.3M | — | ||
| Q4 24 | $107.7M | — | ||
| Q3 24 | $98.8M | $55.2M | ||
| Q2 24 | $108.6M | $55.1M | ||
| Q1 24 | $85.0M | $55.0M |
股东权益BKSYLAB
| Q4 25 | $94.9M | — | ||
| Q3 25 | $91.1M | $399.7M | ||
| Q2 25 | $86.6M | $424.5M | ||
| Q1 25 | $88.8M | $454.6M | ||
| Q4 24 | $94.0M | — | ||
| Q3 24 | $110.3M | $489.3M | ||
| Q2 24 | $76.5M | $510.3M | ||
| Q1 24 | $81.7M | $577.3M |
总资产BKSYLAB
| Q4 25 | $386.2M | — | ||
| Q3 25 | $380.9M | $539.6M | ||
| Q2 25 | $310.8M | $557.0M | ||
| Q1 25 | $284.9M | $579.6M | ||
| Q4 24 | $254.1M | — | ||
| Q3 24 | $245.5M | $681.5M | ||
| Q2 24 | $224.3M | $708.7M | ||
| Q1 24 | $210.1M | $777.7M |
负债/权益比BKSYLAB
| Q4 25 | 2.12× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.41× | — | ||
| Q1 25 | 1.30× | — | ||
| Q4 24 | 1.15× | — | ||
| Q3 24 | 0.90× | 0.11× | ||
| Q2 24 | 1.42× | 0.11× | ||
| Q1 24 | 1.04× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.3M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流BKSYLAB
| Q4 25 | $-9.3M | — | ||
| Q3 25 | $-39.0M | $-22.2M | ||
| Q2 25 | $-7.3M | $-20.7M | ||
| Q1 25 | $27.2M | $-30.3M | ||
| Q4 24 | $-1.8M | — | ||
| Q3 24 | $1.0M | $-27.9M | ||
| Q2 24 | $-1.8M | $-39.0M | ||
| Q1 24 | $-3.8M | $-62.5M |
自由现金流BKSYLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
自由现金流率BKSYLAB
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
资本支出强度BKSYLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BKSY
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
